Weight loss drugs come with warnings and it is important to read them carefully.
Photo Credit: istockphoto
Weight‑loss injections like semaglutide and tirzepatide deliver dramatic results, but there are side effects, including gut discomfort. Studies show nausea, diarrhea, and fatigue are common, while long‑term risks include muscle loss and weight regain. These drugs are powerful tools, but they require medical oversight and lifestyle changes to balance benefits against harms.
If you are thinking of getting weight‑loss drugs or injections to lose that stubborn weight, you need to learn about the side effects too. There have been reports of the side‑effect after these medical interventions, which include upset stomachs to surgery for gallstones and some people lost too much of weight.
None of this means the drugs are bad or good in a simple way. It means you deserve the whole story before your name goes on a prescription.
The best‑known new weight‑loss medicines - semaglutide, tirzepatide and others- all sit in the GLP‑1 (Glucagon-like peptide-1) family. They copy a natural gut hormone that slows the movement of food, helps control blood sugar and, very bluntly, takes the edge off your appetite.
They were built for diabetes. The big surprise came when trial patients started losing a lot of weight, enough for drug makers to test higher weight‑loss doses in people who were not diabetic.
A 2025 trial in The New England Journal of Medicine, comparing tirzepatide with semaglutide, showed very strong weight loss in both groups over about a year and a half, with tirzepatide slightly ahead.1
However, it also found that gut‑related problems were the commonest unwanted effect, especially when doses were being increased.
So, the kilos can come off with these drugs but the fine print is what your body goes through on the way there.
According to the NEJM study and its summaries, in the 2025 investigations of semaglutide and tirzepatide, nausea was reported by four in every ten in either of the two groups, while diarrhea was the complaint of a quarter, and vomiting, indigestion, and fatigue were also often reported as volumes rose.2
A medical study regarding the side effects of GLP-1 that had the date of 2025 has put together similar data on the drug and said, “gastrointestinal problems were by far the most common, especially in the first weeks and with every increase in dose.
Rapid weight loss can be rough on the gallbladder, no matter how you lose it. GLP‑1 drugs seem to add to that pressure for some users.
A 2025 analysis in Expert Opinion on Drug Safety tracked links between these drugs and gallbladder problems. It found a modest but real increase in gallbladder disease, especially gallstones and sudden gallbladder inflammation, in people on GLP‑1 medicines compared with another diabetes‑drug class.3 The risk was higher in those with obesity and big, fast weight drops. Quite a few ended up needing surgery to remove the gallbladder.
The pancreas has been another point of concern. Early warnings mentioned acute pancreatitis, a painful inflammation that can require hospital care.
A 2025 paper in Diabetes Research and Clinical Practice looked for clear predictors of pancreatitis in people starting GLP‑1 drugs for obesity and did not find a big difference between those who did and did not develop it.4
At the same time, safety reviews keep advising caution in anyone who has had pancreatitis before and urge doctors to watch for red‑flag symptoms. The risk may be small for most people, but it is not zero.
When any medicine changes appetite, weight and gut hormones, the next question is obvious, what does it do to mood?
In January 2026, the FDA in the USA stated on their website that after analyzing data from studies and information from insurance databases, they did not find a clear connection between GLP-1 medications and suicidal thoughts or actions.5
A more detailed explanation was given by the psychiatric education company NEI Global in the same month - “A large cohort study of over 2.2 million patients did not demonstrate an increased risk of self-harm in patients using GLP-1 medications, and the ‘suicidal risk’ warnings have been removed from the labels."
That’s reassuring, but not a free pass. Both the FDA and independent experts still recommend that people on these medicines, and their doctors take mood changes seriously and report anything unusual. With millions of new users, even a rare side effect matters.
As more people stay on these drugs, new patterns keep presenting.
GoodRx in 2025, indicated the common effects, which included nausea, vomiting, bowel changes, heartburn, bloating, stomach pain, headaches, dizziness, fatigue, rapid heart rate, thinning of hair, and low blood sugar. These effects were noted in users of the medication.6
Later in the year, the publication JAMA Otolaryngology carried an article that created headlines not because of the effects of the drugs but because of the possible effects of the drugs if taken over an extended period.
The possible effects of the drugs were chronic cough. The publication was based on over two million patient records over two decades.
There is also the quieter issue of what kind of weight is being lost. Mayo Clinic’s community health arm noted in 2025 that over 30% of weight lost on GLP‑1 drugs can come from lean mass, meaning muscle, rather than fat, raising questions about long‑term strength and metabolism if diet and exercise are not addressed alongside.
There is another side effect that is located in the future - weight regain.
A review published in The Lancet Diabetes & Endocrinology in 2025 found out what occurred when patients stopped their GLP-1 medication. On average, patients regained one-third to one-half of the weight they had lost one year after stopping the medication.7
This is similar to what Mayo Clinic and others have found. If lifestyle changes are not made and stick to, the body will tend to return to previous weight levels.
So for many, these medicines are not a course you finish, they are a long‑term commitment. With long‑term commitments, side effects matter even more.
Put all of this together and the picture is complicated, not catastrophic. GLP‑1 weight‑loss drugs can bring big benefits such as low blood sugar, less joint strain, better sleep, reduced risk of heart disease.
They also commonly cause gut problems, slightly raise gallbladder risk, carry a small but watched signal around the pancreas, may affect cough and muscle mass in some, and often lead to weight regain when stopped.
Instead of asking 'Are these drugs safe?' in a yes‑or‑no way, a more honest question would be - 'Given my health history, my other medicines and my support system, do the potential gains outweigh the possible harms,'- and do I have a doctor who will track both with me?'
That means checking where your gallbladder, pancreas, kidneys and mental health stand before starting.
It means insisting on the original, approved products rather than mystery compounded vials from social media. It means knowing which side effects are annoying but manageable and which ones mean stop now and call for help.
Weight loss has never been just about willpower, and these drugs prove that. They’re powerful tools, which come with warnings. Reading them carefully is not pessimism, but self‑preservation.
Disclaimer: This content is for general informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider with any questions about your health or treatment options.
References
1. National Library of Medicine | Tirzepatide Vs Semaglutide for Obesity
2. beLite | Which Weight Loss Drug Works Better
3. National Library of Medicine | GLP-1 receptor agonists and gallbladder disease risk
4. ScienceDirect | Predictors of acute pancreatitis with GLP-1 receptor
5. US FDA | FDA
6. GoodRx | GLP-1 Side Effects
7. ScienceDirect | Expanding role of GLP-1 receptor agonists
At marvelof.com, we spotlight the latest trends and products to keep you informed and inspired. Our coverage is editorial, not an endorsement to purchase. If you choose to shop through links in this article, whether on Amazon, Flipkart, or Myntra, marvelof.com may earn a small commission at no extra cost to you.
